Why does Optivisc M contain Hyaluronic Acid?
Many people associate Hyaluronic Acid with dermal fillers but this valuable ingredient can also serve medical purposes. HA’s use in the treatment of OA has even been approved by the FDA because this substance is highly biocompatible which means that it is well-tolerated by the human organism and it does not trigger harmful unwanted reactions or side effects. It is also fully biodegradable since the body absorbs and dissolves it within months of its application. Injecting Hyaluronic Acid in the joints of OA patients has also been found to be one of the best ways to tackle symptoms like pain and restricted mobility in the joints, swelling, and stiffness, as well as functional impairment and deformities caused by the disease.
- Duration: 6 months
- Injection site: Intra-articular (in the joints)
- Treatment course: 3 injections
- HA function: protective, hydrating, shock-absorbing, synovial fluid-stimulating
Antioxidant-rich viscosupplementation for OA
Optivisc M is the only solution in this product range that contains Mannitol. This is a robust antioxidant that is often paired with Hyaluronic Acid because it greatly boosts its moisturizing powers and it preserves its viscoelastic properties. That increases both the effectivity and durability of this product.